Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Rixing Bio-Tech

company

About

Rixing Bio-Tech engaged in the research and development of anthraquinone, ammonia sugar and other fine chemical products.

  • 251 - 500

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥57M
Industries
Biotechnology,Chemical,Pharmaceutical
Founded date
Jun 1, 2004
Number Of Employee
251 - 500
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥259M
Rixing Bio-Tech has raised a total of ¥259M in funding over 2 rounds. Their latest funding was raised on Mar 31, 2018 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 31, 2018 Post-IPO Equity ¥50M 1 Detail
Feb 17, 2017 Post-IPO Equity ¥102M 6 Detail
Sep 9, 2015 Series Unknown ¥57M 2 Detail
Sep 9, 2013 Series Unknown ¥50M 1 Gaoyoushi Guoyou Zichan Guanli Zhongxin Detail